Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.28 USD | -1.33% | -7.02% | -19.28% |
Business Summary
Number of employees: 159
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Endosomal Escape Vehicle Therapeutics
100.0
%
| 0 | nan % | 129 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 129 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dipal Doshi
CEO | Chief Executive Officer | 48 | 01/17/01 |
Kory Wentworth
DFI | Director of Finance/CFO | 45 | 01/20/01 |
Nathan Dowden
PSD | President | 54 | 04/19/04 |
Chief Tech/Sci/R&D Officer | 62 | 01/17/01 | |
Karla MacDonald
PRN | Corporate Officer/Principal | - | 01/21/01 |
Jared Cohen
LAW | General Counsel | - | 01/20/01 |
Kerry Robert
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Kim
BRD | Director/Board Member | 65 | 01/20/01 |
Mary Thistle
BRD | Director/Board Member | 64 | 04/21/04 |
Gina Chapman
BRD | Director/Board Member | 57 | 01/23/01 |
Dipal Doshi
CEO | Chief Executive Officer | 48 | 01/17/01 |
Kush Parmar
CHM | Chairman | 42 | 01/16/01 |
Bernhardt Zeiher
BRD | Director/Board Member | 60 | 04/23/04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 33,625,578 | 27,644,833 ( 82.21 %) | 24,475 ( 0.0728 %) | 82.21 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.28% | 403M | |
-2.90% | 103B | |
+1.57% | 95.28B | |
+1.46% | 22.15B | |
-16.14% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.28% | 16.05B | |
+5.54% | 13.68B | |
+33.14% | 12.17B |
- Stock Market
- Equities
- TRDA Stock
- Company Entrada Therapeutics, Inc.